Your Guide To Doctors, Health Information, and Better Health!
Your Health Magazine Logo
The following article was published in Your Health Magazine. Our mission is to empower people to live healthier.
Your Health Magazine Contributor
Understanding SPRAVATO Treatment for Persistent Depression Symptoms
Your Health Magazine Contributor
. https://YourHealthMagazine.net

Understanding SPRAVATO Treatment for Persistent Depression Symptoms

Persistent depression symptoms can affect many areas of daily life, including work, relationships, sleep, and motivation. While antidepressants and therapy can help many people, some individuals continue to experience significant symptoms despite trying traditional treatment approaches.

For eligible adults, SPRAVATO treatment may provide another option to discuss with a qualified mental health professional. The treatment uses esketamine nasal spray and is administered under medical supervision as part of a structured depression treatment plan.

What Is SPRAVATO Treatment?

SPRAVATO is a prescription nasal spray containing esketamine. It works differently from many traditional antidepressants by targeting the brain’s glutamate system.

Unlike medications that are taken independently at home, SPRAVATO is administered in a certified healthcare setting. Patients are monitored following administration before they leave the facility.

SPRAVATO is approved for certain adults with treatment-resistant depression and, in conjunction with an oral antidepressant, for depressive symptoms in adults with major depressive disorder who have acute suicidal ideation or behavior. A healthcare provider must evaluate the individual’s medical history and treatment needs before recommending it. A healthcare provider must evaluate the individual’s medical history and treatment needs before recommending it.

Why Do Depression Symptoms Persist?

Depression can be complex, and symptoms do not always improve after the first treatment approach. Several factors can influence how someone responds to treatment, including the severity of symptoms, previous medications, treatment adherence, coexisting conditions, and individual differences in how the brain responds to medication.

Persistent symptoms may include:

  • Low mood or feelings of sadness
  • Loss of interest in normal activities
  • Difficulty concentrating
  • Changes in sleep
  • Low energy or motivation
  • Feelings of hopelessness
  • Changes in appetite

When these symptoms continue despite treatment, discussing additional options with a qualified provider can help determine what approaches may be appropriate.

How Does SPRAVATO Work?

SPRAVATO contains esketamine, which affects the glutamate system in the brain. Glutamate is an important neurotransmitter involved in communication between nerve cells.

This mechanism is different from many commonly prescribed antidepressants. Because of this difference, SPRAVATO may be considered for certain adults whose depression has not improved sufficiently with other treatments.

The treatment response varies between individuals, so patients should discuss realistic expectations with their healthcare provider.

What Happens During a SPRAVATO Treatment Session?

SPRAVATO treatment follows a supervised process designed to help protect patient safety.

A treatment visit generally involves:

  1. Pre-treatment assessment: The healthcare team reviews the patient’s condition and confirms that treatment can proceed.
  2. SPRAVATO administration: The prescribed nasal spray is administered under professional supervision.
  3. Monitoring period: The patient remains at the healthcare facility while the care team monitors them.
  4. Discharge: Once the required observation period is complete and the provider determines it is appropriate, the patient can leave.

Because SPRAVATO can cause temporary effects such as sedation, dizziness, nausea, and dissociation or changes in perception, patients are monitored for at least two hours after each treatment session. Patients should arrange transportation home and should not drive or operate machinery until the next day after a restful sleep, following their provider’s instructions.

Who May Be Considered for SPRAVATO?

SPRAVATO is not appropriate for everyone experiencing depression. A healthcare provider will consider factors such as previous antidepressant treatments, current symptoms, medical history, medications, and other individual circumstances.

Adults who continue to experience significant depression symptoms despite previous treatment may want to ask their psychiatric provider whether SPRAVATO could be appropriate.

A professional evaluation is important because the treatment plan should be based on the patient’s specific needs rather than symptoms alone.

SPRAVATO and Other Depression Treatment Options

SPRAVATO is one potential component of a broader approach to depression care. Depending on the individual, treatment may involve medication management, psychotherapy, lifestyle changes, or other evidence-based interventions.

For someone who has already tried conventional antidepressants without adequate improvement, discussing additional depression treatment options with a qualified provider can help clarify what choices are available.

The goal is not simply to add another treatment but to develop an approach that considers the person’s symptoms, previous treatment history, overall health, and treatment goals.

Finding SPRAVATO Treatment in the Ann Arbor Area

People looking for SPRAVATO treatment in Ann Arbor can discuss their symptoms and previous treatment experiences with a qualified psychiatric provider. Access to local care can make it easier to receive the required supervision and follow-up throughout treatment.

Family Care Psychiatry provides psychiatric care for patients in Ann Arbor and surrounding communities, including Canton, Brighton, Plymouth, Ypsilanti, and Chelsea. The practice also serves surrounding areas across Washtenaw County, Wayne County, Livingston County, and Jackson County.

What Should Patients Ask Before Starting SPRAVATO?

Before beginning treatment, patients may want to ask their provider:

  • Why is SPRAVATO being considered for my depression?
  • How does it differ from my previous medications?
  • How often will treatment sessions take place?
  • What should I expect during a session?
  • What side effects should I know about?
  • How will my progress be monitored?
  • What other treatment options are available?

Having these questions answered can help patients understand the treatment process and make informed decisions with their healthcare provider.

Understanding the Role of Professional Psychiatric Care

Persistent depression symptoms can require careful evaluation rather than simply trying one treatment after another. A psychiatric professional can review previous treatment attempts and help determine whether an alternative approach may be appropriate.

For individuals considering advanced depression treatments, working with an experienced provider can also provide guidance throughout the treatment process, from initial assessment to ongoing monitoring.

Final Thoughts

Persistent depression symptoms can be challenging, particularly when traditional treatments have not provided enough improvement. SPRAVATO offers a different treatment approach that may be considered for certain eligible adults with difficult-to-treat depression.

The most appropriate treatment depends on the individual’s symptoms, medical history, previous treatment response, and overall needs. Speaking with a qualified psychiatric provider is an important step toward understanding whether SPRAVATO or another treatment approach may be suitable.

www.yourhealthmagazine.net
MD (301) 805-6805 | VA (703) 288-3130